BSPHO News
BSPHO Clinical Trial Day 2024: Highlights
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
News
All news
.png?width=3072&format=webp)
BSPHO News
Royal Decree on paediatric oncology in Belgium
The amendment to the Royal Decree on paediatric oncology which groups patients in a smaller number of reference centres and creates networks to organise parts of the treatment trajectory close to the patient's home is published.
New Study Open
iEuroEwing: New trial for Ewing sarcoma patients launched in Belgium
In June 2024, the International Euro Ewing (iEuroEwing) trial was launched to evaluate treatment optimisation in patients with Ewing sarcoma.
BSPHO News
BSPHO Scientific Meeting February 2024
The first BSPHO Scientific Meeting of 2024 brought together physicians and researchers to discuss paediatric haemato-oncology advancements.
New Study Open
NORDIC: Study investigating speech issues in paediatric brain tumour patients
In January 2024, the NORDIC trial launched and will evaluate Cerebellar Mutism Syndrome in children undergoing brain tumour surgery.
Job Vacancy
Job Vacancy: Hemato-Oncology Clinical Studies Coordinator - HUDERF
The Department of Pediatric Hemato-Oncology at the Queen Fabiola Children's University Hospital (HUDERF) is recruiting a Hemato-Oncology Clinical Studies Coordinator (CDI - 38H).
New Study Open
New registry open : RELIVE
In October 2023, a new registry (RELIVE) was open in Belgium.
New Study Open
ALCL-VBL: New Trial for Paediatric non-Hodgkin Lymphoma Patients launched in Belgium
In September 2023, ALCL-VBL trial was launched to evaluate Vinblastine treatment for children under 18 with Anaplastic Large Cell Lymphoma.
Recommended news
BSPHO News
BSPHO Clinical Trial Day 2024: Highlights
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
BSPHO News
Royal Decree on paediatric oncology in Belgium
The amendment to the Royal Decree on paediatric oncology which groups patients in a smaller number of reference centres and creates networks to organise parts of the treatment trajectory close to the patient's home is published.
New Study Open
iEuroEwing: New trial for Ewing sarcoma patients launched in Belgium
In June 2024, the International Euro Ewing (iEuroEwing) trial was launched to evaluate treatment optimisation in patients with Ewing sarcoma.
BSPHO News
BSPHO Scientific Meeting February 2024
The first BSPHO Scientific Meeting of 2024 brought together physicians and researchers to discuss paediatric haemato-oncology advancements.
New Study Open
NORDIC: Study investigating speech issues in paediatric brain tumour patients
In January 2024, the NORDIC trial launched and will evaluate Cerebellar Mutism Syndrome in children undergoing brain tumour surgery.
New Study Open
ALCL-VBL: New Trial for Paediatric non-Hodgkin Lymphoma Patients launched in Belgium
In September 2023, ALCL-VBL trial was launched to evaluate Vinblastine treatment for children under 18 with Anaplastic Large Cell Lymphoma.
Pharma News
BAYER's 'Detective Didi & Sidekick' Childhood Cancer Booklet
New booklet by BAYER: 'Detective Didi & Sidekick' - Helping Kids Understand Cancer.
New Study Open
FaR-RMS: A new study for children and adults with rhabdomyosarcoma launched in Belgium
New study launched: FaR-RMS study investigates novel treatments for pediatric and adult Rhabdomyosarcoma patients, aiming to enhance outcomes.
Partners' News
E-book publication: Cancer in children and adolescents
The Belgian Cancer Registry presents its latest publication 'Cancer in children and adolescents in Belgium 2004-2020'.
BSPHO News
Neuroblastoma Educational Materials
We are pleased to share Neuroblastoma educational materials developed by the working groups (WG) for patients and their families. Learn more about it and find the material here!
BSPHO News
BSPHO coordinated the evacuation of 4 Ukrainian children with cancer
BSPHO coordinated the arrival of 4 Ukrainian children with cancer in Belgium to ensure the best care for patients and their families.